Have a personal or library account? Click to login
Cephalosporin-induced hemolytic anemia: a case study Cover

Cephalosporin-induced hemolytic anemia: a case study

Paid access
|Dec 2025

References

  1. Cohn CS, Delaney M, Johnson ST, et al., Eds. Technical manual. 21st ed. Bethesda, MD: AABB, 2023.
  2. Garratty G. Drug-induced immune hemoly tic anemia. Hematology Am Soc Hematol Educ Program 2009:73–9.
  3. Kumar S, Bansal R, Bansal P, Dhamija RK. Ceftriaxone-induced hemolytic anemia: a rare case report. Perm J 2020;24:19.088.
  4. Vehapoglu A, Göknar N, Tuna R, Cakir FB. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin. Turk J Pediatr 2016; 58:216–6. doi: 10.24953/turkjped.2016.02.016.
  5. Johnson ST, Fueger JT, Gottschall JL. One center’s experience: the serology and drugs associated with drug-induced immune hemolytic anemia: a new paradigm. Transfusion 2007;47:697–702. doi: 10.1111/j.1537-2995.2007.01173.x.
  6. Mayer B, Bartolmäs T, Yürek S, Salama A. Variability of findings in drug-induced immune hemoly tic anemia: experience over 20 years in a single center. Transfus Med Hemother 2015;42:333–9. doi: 10.1159/000440673.
  7. Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239–46. doi: 10.1046/j.1537-2995.1999.39111239.x.
  8. Leicht HB, Weinig E, Mayer B, Viebahn J, Geier A, Rau M. Ceftriaxone-induced hemoly tic anemia with severe renal failure: a case report and review of literature. BMC Pharmacol Toxicol 2018;19. doi: 10.1186/s40360-018-0257-7.
  9. Petz LD, Garratty G. Immune hemolytic anemia. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2005.
  10. Branch DR. Drug-induced immune hemolytic anemias. ISBT Sci Ser 2019;14:49–52.
  11. Bougie DW, Wilker PR, Aster RH. Patients with quinine- induced immune thrombocy topenia have both “drug-dependent” and “drug-specific” antibodies. Blood 2006;108: 922–7.
  12. Zhu J, Zhu J, Bougie DW, Aster RH, Springer TA. Structural basis for quinine-dependent antibody binding to platelet integrin αIIbβ3. Blood 2015;126:2138–45.
  13. Malloy CA, Kiss JE, Challapalli M. Cefuroxime-induced immune hemolysis. J Pediatr 2003;143:130–2.
  14. Barton LL. Cefuroxime-induced immune hemolysis. J Pediatr 2004;144:690; author reply: 690. doi: 10.1016/j.jpeds. 2004.01.038.
  15. Arndt PA, Garratty G. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other cephalosporins and penicillin. Am J Clin Pathol 2002;118:256–62. doi: 10.1309/jfje-vukn-221t-g6ev.
  16. Sharma A, Chamberlain S, Mannuru D, Matta A. A n uncommon incidence of drug-induced immune hemolytic anemia secondary to ceftriaxone. Cureus 2021. doi: 10.7759/ cureus.20682.
DOI: https://doi.org/10.2478/immunohematology-2025-016 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 111 - 116
Published on: Dec 31, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Graça Almeida, Ana Costa, Eugénia Vasconcelos, published by American National Red Cross
This work is licensed under the Creative Commons License.